In 2012, Ebi2 was identified as an IBD risk gene by genome-wide association studies (GWAS) and a single nucleotide polymorphism in Ebi2 increase the risk for both, CD and UC with genome wide significance [103]. The gene discussed is GPR183; the disease is inflammatory bowel disease.